Skip to main content
Erschienen in: Wiener klinische Wochenschrift 23-24/2018

15.08.2018 | images in clinical medicine

Intuity™ aortic valve thrombosis

verfasst von: Martina Krajnc, M.D., Matevz Jan, M.D., Katja Azman Juvan, M.D., PhD, Prof. Tomislav Klokocovnik, M.D., PhD

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 23-24/2018

Einloggen, um Zugang zu erhalten

Excerpt

In 2017 a 79-year-old male presented 2 years after biological sutureless aortic valve replacement (Intuity™, 25 mm [Edwards Lifesciences Corporation, Irvine, CA, USA]) and mitral valve repair with worsening heart failure, severe thrombocytopenia and negative hemocultures. Prior to the first procedure in 2015, an echocardiogram showed severe enlargement of the left ventricle, with mild concentric thickening of the walls. Global systolic function of the left ventricle was mildly reduced with left ventricular ejection fraction (LVEF) of 45%. Akinesia of the basal segment of the inferior septum and hypokinesia to akinesia of basal and medial segments of the inferior wall were noticed. Left atrium was also enlarged, while the right chambers appeared of normal size. Coronarography revealed no visible disease or luminal irregularities of coronary arteries with no stenosis of two drug-eluting stents (DES) in the right coronary artery (RCA) that were inserted in 2012. Transthoracic echocardiography (TTE) on admission in 2017 showed symmetrically thickened leaflets of the Intuity™ valve (Fig. 1), maximum pressure gradient (maxPG) of 49 mm Hg, estimated aortic valve area (AVA) of 0.6 cm2 and LVEF of 26%.
Literatur
1.
Zurück zum Zitat Baumgartner H, Falk V, Bax JJ, et al. ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;2017(38):2739–91.CrossRef Baumgartner H, Falk V, Bax JJ, et al. ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;2017(38):2739–91.CrossRef
2.
Zurück zum Zitat Barnhart GR, Accola KD, Grossi EA, et al. TRANSFORM (Multicenter Experience With Rapid Deployment Edwards INTUITY Valve System for Aortic Valve Replacement) US clinical trial: Performance of a rapid deployment aortic valve. J Thorac Cardiovasc Surg. 2017;153:241–51.CrossRef Barnhart GR, Accola KD, Grossi EA, et al. TRANSFORM (Multicenter Experience With Rapid Deployment Edwards INTUITY Valve System for Aortic Valve Replacement) US clinical trial: Performance of a rapid deployment aortic valve. J Thorac Cardiovasc Surg. 2017;153:241–51.CrossRef
3.
Zurück zum Zitat Kocher AA, Laufer G, Haverich A, et al. One-year outcomes of the Surgical Treatment of Aortic Stenosis With a Next Generation Surgical Aortic Valve (TRITON) trial: A prospective multicenter study of rapid-deployment aortic valve replacement with the EDWARDS INTUITY Valve System. J Thorac Cardiovasc Surg. 2013;145:110–6.CrossRefPubMed Kocher AA, Laufer G, Haverich A, et al. One-year outcomes of the Surgical Treatment of Aortic Stenosis With a Next Generation Surgical Aortic Valve (TRITON) trial: A prospective multicenter study of rapid-deployment aortic valve replacement with the EDWARDS INTUITY Valve System. J Thorac Cardiovasc Surg. 2013;145:110–6.CrossRefPubMed
Metadaten
Titel
Intuity™ aortic valve thrombosis
verfasst von
Martina Krajnc, M.D.
Matevz Jan, M.D.
Katja Azman Juvan, M.D., PhD
Prof. Tomislav Klokocovnik, M.D., PhD
Publikationsdatum
15.08.2018
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 23-24/2018
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-018-1380-6

Weitere Artikel der Ausgabe 23-24/2018

Wiener klinische Wochenschrift 23-24/2018 Zur Ausgabe

MUW researcher of the month

MUW researcher of the month

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.